Comparing Sintx Technologies (SINT) & Its Competitors

Sintx Technologies (NASDAQ:SINT) is one of 511 publicly-traded companies in the “Healthcare Equipment & Supplies” industry, but how does it compare to its competitors? We will compare Sintx Technologies to similar businesses based on the strength of its institutional ownership, valuation, profitability, earnings, analyst recommendations, dividends and risk.

Analyst Recommendations

This is a summary of current ratings and target prices for Sintx Technologies and its competitors, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sintx Technologies	1	0	3	0	2.50
Sintx Technologies Competitors	4281	10558	18338	829	2.46

Sintx Technologies presently has a consensus target price of $9.50, suggesting a potential upside of 516.88%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 18.79%. Given Sintx Technologies’ stronger consensus rating and higher probable upside, analysts plainly believe Sintx Technologies is more favorable than its competitors.

Profitability

This table compares Sintx Technologies and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Sintx Technologies	-848.20%	-354.44%	-115.37%
Sintx Technologies Competitors	-276.78%	-149.08%	-21.73%

Institutional & Insider Ownership

18.4% of Sintx Technologies shares are owned by institutional investors. Comparatively, 40.6% of shares of all “Healthcare Equipment & Supplies” companies are owned by institutional investors. 8.1% of Sintx Technologies shares are owned by company insiders. Comparatively, 15.0% of shares of all “Healthcare Equipment & Supplies” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Earnings & Valuation

This table compares Sintx Technologies and its competitors revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Sintx Technologies	$1.02 million	-$10.36 million	-0.31
Sintx Technologies Competitors	$1.87 billion	$138.21 million	12.61

Sintx Technologies’ competitors have higher revenue and earnings than Sintx Technologies. Sintx Technologies is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Summary

Sintx Technologies competitors beat Sintx Technologies on 8 of the 11 factors compared.

About Sintx Technologies

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.